Andrew James Norstrud

CIK: 0001311402

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

UPXI

UPEXI, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

UPXI
UPEXI, INC.
Jul 3, 2026
Award(A)
Direct
400K shares-
UPXI
UPEXI, INC.
Oct 1, 2025
Award(A)
Direct
240K shares-
UPXI
UPEXI, INC.
Jul 16, 2025
Award(A)
Direct
250K shares-
UPXI
UPEXI, INC.
Apr 17, 2025
Purchase(P)
Direct
43.9K shares at avg. $2.28$100K
UPXI
UPEXI, INC.
Apr 17, 2025
Award(A)
Direct
100K shares-

		Type	Shares	Price		Ownership
Jul 3, 2026	UPXI UPEXI, INC.	Award(A)	400,000	-	$0	Direct
Oct 1, 2025	UPXI UPEXI, INC.	Award(A)	240,000	-	-	Direct
Jul 16, 2025	UPXI UPEXI, INC.	Award(A)	250,000	-	-	Direct
Apr 17, 2025	UPXI UPEXI, INC.	Purchase(P)	43,860	$2.28	$100,001	Direct
Apr 17, 2025	UPXI UPEXI, INC.	Award(A)	100,000	-	-	Direct

1-5 of 5 transactions

About Norstrud Andrew James

Norstrud Andrew James (SEC CIK 0001311402) files insider reports with the SEC as Chief Financial Officer of UPEXI, INC. (UPXI).

Signal8 holds 4 ownership filings by Norstrud Andrew James, all Form 4s, filed between Apr 25, 2025 and Jul 20, 2026. Those filings report 5 transactions, from Apr 17, 2025 to Jul 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Norstrud Andrew James's filings is in TAMPA, FL.

Recent filings by Norstrud Andrew James

Jul 3, 2026: Grant or award of UPXI shares (Form 4, code A).
Oct 1, 2025: Grant or award of UPXI shares (Form 4, code A).
Jul 16, 2025: Grant or award of UPXI shares (Form 4, code A).
Apr 17, 2025: Open-market purchase of UPXI shares (Form 4, code P).
Apr 17, 2025: Grant or award of UPXI shares (Form 4, code A).

Other insiders filing for UPEXI, INC. (UPXI)

Salkind Gene, Director
Dugan Lawrence, Director
Rudick Brian Benjamin, Chief Strategy Officer
MARSHALL ALLAN, Chief Executive Officer
Williams Thomas Charles, Director

How to read Form 4 transaction codes